- Acquired by InterCure, Sep 2018
- Raised $12M Undisclosed Round, Nov 2018
About
CANNDOC Pharma is a pioneer in the medical cannabis industry, developing and providing pharma-grade cannabis solutions to achieve better patient health and therapy. The company focuses on validating clinical significance through trials with hospitals and universities, and its products are held to the highest pharmaceutical standards, meeting global Good Manufacturing Practice (GMP) regulatory requirements. CANNDOC offers products for various diseases like neuropathic pain, relief of pain of cancerous source, inflammatory bowel disease, post-traumatic stress disorder, Parkinson's, and epileptic seizures. Canndoc has been pioneering Pharma-Grade cannabis for more than 15 years, providing millions of doses to 40,000 patients.
Funding history · 1 round · $12.0M total
Headcount over time
Q&A
- What is CANNDOC Pharma's primary business?
- CANNDOC Pharma develops pharma-grade cannabis products, focusing on research, cultivation, processing, and product development, with a GMP clinical trial pipeline.
- When was CANNDOC Pharma founded?
- CANNDOC Pharma was founded in January 2008.
- Who acquired CANNDOC Pharma and when?
- CANNDOC Pharma was acquired by InterCure in September 2018.
- What is the employee count of CANNDOC Pharma?
- CANNDOC Pharma has 1-10 employees.
- What medical conditions do CANNDOC Pharma's products address?
- CANNDOC Pharma's GMP-standard products are prescribed for conditions such as neuropathic pain, cancer pain, inflammatory bowel disease, post-traumatic stress disorder, Parkinson's disease, and epileptic seizures.
- In which countries are CANNDOC Pharma's products and genetics regulated?
- CANNDOC Pharma's products and genetics comply with regulatory requirements in Europe, Canada, and Israel.
- Who is the CEO of CANNDOC Pharma?
- Alexander Rabinovitch is the CEO of CANNDOC Pharma.
- What is the primary sector of CANNDOC Pharma?
- CANNDOC Pharma's primary sector is Health Tech & Life Sciences.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | canndoc.com/ |
|---|---|
| linkedin.com/company/13028545 |
Identifiers & details
| Legal name | Canndoc Ltd. |
|---|---|
| Founded | 2008 |
| Employees (exact) | 8 |
| Status reason | Acquired by InterCure on Sep 2018 |
Acquisitions & public offerings
Acquired by InterCure 2018-09
Radar intelligence
Web history (Wayback)
| Domain | canndoc.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514418581 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2010-03-07 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | מדינת היהודים 85 הרצליה |